This blog post focuses on the implications of leaked government crypto strategy details, emphasizing the bullish outlook for Bitcoin. The content mirrors the data-driven, news-heavy style often seen in high-performing posts on The Street.
Chipmaker Kioxia drops October listing plan, biggest Tokyo initial public offering in 2024
Japanese chipmaker Kioxia Holdings Corp. no longer plans to list its shares on the Tokyo Stock Exchange in October, which could have ...
3 Japanese Stocks That May Be Undervalued Based On Current Estimates
Japan’s stock markets have recently seen significant gains, with the Nikkei 225 Index rising 3.1% and the broader TOPIX Index up 2.8%, driven by a weaker yen following the U.S. Federal Reserve's ...
Top Japanese Growth Stocks With High Insider Ownership September 2024
Japan's stock markets have shown robust performance, with the Nikkei 225 Index gaining 3.1% and the broader TOPIX Index up 2.8%, partly driven by a weaker yen following the U.S. Federal Reserve's ...
Japan’s Nikkei hits 3-week high on Wall Street strength, dovish BOJ
TOKYO: Japan’s Nikkei share average climbed to a three-week high on Tuesday as markets resumed trade after a long holiday weekend, with Wall Street’s overnight gains and the Bank of Japan’s dovish ...
Ueda Signals No Rush to Hike, Citing Time to Weigh Policy
Governor Kazuo Ueda reinforced his message that while the Bank of Japan will raise its key interest rate again if data allow, authorities won’t be in a hurry to do so, in remarks that indicate little ...
How Democrats Have Shifted on Crypto
While Democrats are yet to outline much crypto policy, the Democratic National Convention showed a significant change in tone, say Justin Slaughter and Sheila Warren.
Exclusive-Bain-backed chipmaker Kioxia scraps October IPO plan, sources say
By Miho Uranaka and Sam Nussey TOKYO (Reuters) -Bain-backed memory chipmaker Kioxia has scrapped its plan for an initial public offering (IPO) in October, three sources familiar with the matter said.
Memory chipmaker Kioxia calls off October IPO plans in Japan – report
Private equity firm Bain Capital-backed chipmaker Kioxia has called off IPO plans for October in Japan, Reuters reported, citing people with knowledge of the matter. Last month, reportedly, Bain was ...
Japan Building ‘Zeta-Class’ Supercomputer, 1,000 Times Faster Than Today’s Fastest Machines
This groundbreaking technology, expected to be operational by 2030, will be a significant step forward in AI development and scientific research.
Undiscovered Gems in Japan for September 2024
Japan’s stock markets have seen a notable rise, with the Nikkei 225 Index gaining 3.1% and the broader TOPIX Index up 2.8%, driven by a weakened yen following the U.S. Federal Reserve's recent rate cut.
Japan’s fiscal health put on backburner in race to choose next PM
Japan's fiscal health, the worst among advanced nations, is unlikely to improve under its next prime minister, with discussion of the ...
BOJ chief signals no rush in raising rates further
The Bank of Japan can afford to spend time scrutinising market and overseas economic developments in setting monetary policy, governor Kazuo Ueda said on Tuesday, suggesting that the central bank was ...
BOJ chief signals no rush in raising rates further
The Bank of Japan can afford to spend time scrutinising market and overseas economic developments in setting monetary policy, governor Kazuo Ueda said on Tuesday, suggesting that the central bank was ...
Takeda Receives Approval for FRUZAQLA (fruquintinib) in Japan for the Treatment of Unresectable Advanced or Recurrent Colorectal Cancer
Takeda (TSE:4502/NYSE:TAK) today announced that it has received approval from the Japanese Ministry of Health, Labour and Welfare to manufacture and market FRUZAQLA Capsules 1mg/5mg (generic name: ...
Takeda Receives Approval for FRUZAQLA (fruquintinib) in Japan for the Treatment of Unresectable Advanced or Recurrent Colorectal Cancer
Takeda (TSE:4502/NYSE:TAK) today announced that it has received approval from the Japanese Ministry of Health, Labour and Welfare to manufacture and market FRUZAQLA Capsules 1mg/5mg (generic name: ...